Diego A. Pedroza, Ph.D.
@dapedroza.bsky.social
Instructor, MOSAIC K99/R00 scholar, Baylor College of Medicine
Reposted by Diego A. Pedroza, Ph.D.
4. A new @natcomms.nature.com paper from ACS-funded postdoctoral fellow Dr. @dapedroza.bsky.social at @bcmhouston.bsky.social describing a new combined immuno-chemotherapy approach that effectively targets macrophage-rich metastatic triple negative breast cancer.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers - Nature Communications
Metastatic triple negative breast cancer (mTNBC) has limited treatments options. Here, this group presents a combination of low-dose cyclophosphamide, anti-CSF1R, and anti-PD-1 therapies to boost immu...
www.nature.com
January 16, 2026 at 11:06 PM
4. A new @natcomms.nature.com paper from ACS-funded postdoctoral fellow Dr. @dapedroza.bsky.social at @bcmhouston.bsky.social describing a new combined immuno-chemotherapy approach that effectively targets macrophage-rich metastatic triple negative breast cancer.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Diego A. Pedroza, Ph.D.
You'll read more about Judge Young's speech on this. And I'll post it here. A powerful proclamation of the Trump Administration's discriminatory actions and the Court's imperative to call it out.
Wow. Incredible hearing.
Wow. Incredible hearing.
June 16, 2025 at 6:29 PM
You'll read more about Judge Young's speech on this. And I'll post it here. A powerful proclamation of the Trump Administration's discriminatory actions and the Court's imperative to call it out.
Wow. Incredible hearing.
Wow. Incredible hearing.
Congrats Bisrat!
March 27, 2025 at 3:47 PM
Congrats Bisrat!